All Stories

  1. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update

    Article • Expert Opinion on Investigational Drugs, August 2019, Taylor & Francis

    Emmanuella Guenova

  2. Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome

    Article • Leukemia & Lymphoma, January 2019, Taylor & Francis

    Emmanuella Guenova

  3. Pseudolymphomatous Reaction to Red Tattoo Pigment

    Article • Case Reports in Dermatology, June 2018, Karger Publishers

    Emmanuella Guenova

  4. PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

    Article • OncoImmunology, February 2018, Taylor & Francis

    Emmanuella Guenova

  5. PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer

    Article • OncoImmunology, August 2017, Taylor & Francis

    Emmanuella Guenova

  6. Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)

    Article • Case Reports in Dermatology, March 2017, Karger Publishers

    Emmanuella Guenova

  7. Toxic epidermal necrolysis

    Article • F1000Research, May 2016, Faculty of 1000, Ltd.

    Emmanuella Guenova

  8. Systemic corticosteroids for subcutaneous panniculitis‐like T‐cell lymphoma

    Article • British Journal of Dermatology, September 2014, Oxford University Press (OUP)

    Emmanuella Guenova